Status:

COMPLETED

A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan

Lead Sponsor:

AbbVie

Conditions:

Pyoderma Gangrenosum

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This study is designed to investigate the efficacy, safety and pharmacokinetics of adalimumab in subjects in Japan with active ulcer(s) due to Pyoderma Gangrenosum (PG).

Eligibility Criteria

Inclusion

  • Participant must be able and willing to provide written informed consent. If the participant is \< 20 years old, a parent or legal guardian must be willing to give written informed consent
  • Participants must have a diagnosis of ulcerative (classic) PG made by the Investigator
  • Participants must have demonstrated an inadequate response to conventional PG therapy or in the opinion of the Investigator they are not a suitable candidate for conventional PG treatment.

Exclusion

  • Participants with pustular, bullous/atypical, or vegetative variants of PG
  • Participants with clinical evidence of ulceration that is non-PG related, vasculitis, thrombosisprone conditions, or monoclonal gammopathy
  • Participants with a histopathological finding that is consistent with a diagnosis other than PG
  • Participants receiving a therapeutic dose of prednisolone
  • Participants with prior exposure to adalimumab or previous participation in an adalimumab clinical study.

Key Trial Info

Start Date :

October 27 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 21 2020

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT03311464

Start Date

October 27 2017

End Date

April 21 2020

Last Update

March 9 2021

Active Locations (20)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (20 locations)

1

Nagoya City University Hospital /ID# 164510

Nagoya, Aichi-ken, Japan, 467-8602

2

Juntendo University Urayasu Hospital /ID# 164422

Urayasu Shi, Chiba, Japan, 279-0021

3

Fukuoka University Hospital /ID# 164416

Fukuoka, Fukuoka, Japan, 814-0180

4

Fukushima Medical University Hospital /ID# 164358

Fukushima, Fukushima, Japan, 960-1295